CN Stock MarketDetailed Quotes
688505 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.
- 6.42
- -0.17-2.58%
Market Closed Aug 23 15:00 CST
6.65BMarket Cap60.00P/E (TTM)
6.65High6.39Low16.61KlotVolume6.60Open6.59Pre Close10.74MTurnover0.23%Turnover Ratio61.14P/E (Static)1.04BShares10.6452wk High2.82P/B4.56BFloat Cap6.0452wk Low7.91Limit Up710.57MShs Float42.09Historical High5.27Limit Down3.95%Amplitude6.04Historical Low0.09Dividend TTM6.47Avg Price10.20KlotAsk1.40%Div YieldTTM100Lot Size6.18KlotBid
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -21.94%408.12M | -21.94%147.65M | -17.50%850.73M | -1.16%707.96M | 92.74%522.83M | 34.33%189.15M | -9.57%1.03B | 2.60%716.27M | -32.02%271.26M | 11.57%140.81M |
| Operating revenue | -21.94%408.12M | -21.94%147.65M | -17.50%850.73M | -1.16%707.96M | 92.74%522.83M | 34.33%189.15M | -9.57%1.03B | 2.60%716.27M | -32.02%271.26M | 11.57%140.81M |
| Total operating cost | -26.27%322.99M | -12.60%145.21M | -18.27%742.53M | -10.13%600.14M | 46.02%438.05M | 12.03%166.15M | -6.12%908.47M | 12.63%667.79M | -9.17%299.99M | 17.78%148.31M |
| Operating cost | -29.29%29.4M | -37.30%10.88M | -15.98%70.63M | -0.19%54.97M | 47.73%41.58M | 63.02%17.35M | 3.84%84.06M | 12.29%55.07M | 11.06%28.14M | 39.09%10.64M |
| Operating tax surcharges | 23.47%2.8M | 2.69%1.27M | -21.21%5.39M | -0.93%3.89M | -13.01%2.27M | -30.63%1.23M | 11.26%6.84M | 1.44%3.93M | 18.96%2.61M | 39.56%1.78M |
| Operating expense | -54.06%114.49M | -28.45%59.71M | -30.84%383.59M | -13.07%333.64M | 86.58%249.23M | 3.11%83.44M | -7.51%554.63M | 10.75%383.82M | -27.45%133.57M | 24.77%80.93M |
| Administration expense | -14.86%23.37M | 9.10%10.98M | -4.48%42.86M | -29.03%39.08M | -21.45%27.45M | 32.05%10.06M | -25.91%44.87M | 44.73%55.06M | 58.66%34.95M | 7.20%7.62M |
| Financial expense | -291.14%-1.68M | -2,247.64%-1.23M | 57.86%-3.7M | 100.98%19.42K | 76.83%-428.55K | 95.22%-52.42K | -115.00%-8.79M | 47.76%-1.99M | -9.92%-1.85M | -56.11%-1.1M |
| -Interest expense (Financial expense) | -85.14%270.8K | -82.45%162.31K | 99.33%3.07M | 160.55%2.68M | 145.42%1.82M | 165.95%924.66K | 45.79%1.54M | 167.75%1.03M | 85.69%742.39K | 89.60%347.69K |
| -Interest Income (Financial expense) | 15.09%-1.98M | -34.66%-1.41M | 29.41%-7.97M | 3.07%-3.85M | 5.13%-2.34M | 35.34%-1.05M | -119.96%-11.29M | -926.86%-3.97M | -13.84%-2.46M | -75.43%-1.62M |
| Research and development | 31.06%154.59M | 17.54%63.62M | 7.46%243.76M | -1.95%168.54M | 15.01%117.95M | 11.73%54.12M | 1.10%226.85M | 7.97%171.89M | 4.37%102.56M | 5.94%48.44M |
| Credit Impairment Loss | -25.20%-35.75M | 77.06%-5.56M | -1,102.93%-24.2M | -36.45%-30.93M | 28.77%-28.55M | -833.59%-24.23M | 328.24%2.41M | -411.51%-22.67M | -239.53%-40.09M | 183.91%3.3M |
| Asset Impairment Loss | 7.84%-1.18M | 88.91%-116.02K | -187.58%-8.45M | 47.37%-2.25M | -18,392.84%-1.28M | -1,687.54%-1.05M | -4,356.07%-2.94M | ---4.27M | --7K | --65.92K |
| Other net revenue | ||||||||||
| Invest income | -3.01%2.76M | -39.44%1.08M | -238.31%-4.35M | -50.82%2.64M | -51.55%2.85M | 18.02%1.78M | -106.19%-1.28M | -47.18%5.36M | -35.12%5.88M | -72.99%1.51M |
| -Including: Investment income associates | -0.86%-7.49M | -11.38%-3.47M | -15.39%-23.54M | -42.87%-12.38M | -99.42%-7.43M | -13.58%-3.12M | -1,173.21%-20.4M | -57.59%-8.67M | -31.48%-3.72M | -221.70%-2.75M |
| Asset deal income | -90.42%141.12K | -83.20%127.99K | -84.63%295.35K | -6.32%1.29M | 139.32%1.47M | 197.60%761.95K | 7.68%1.92M | 27.99%1.38M | 1.37%615.68K | 50.76%256.03K |
| Other revenue | 425.12%21.11M | 0.16%3.22M | 144.43%25.58M | 123.58%5.55M | 160.48%4.02M | 268.28%3.22M | -51.74%10.47M | -36.76%2.48M | -18.19%1.54M | -11.35%873.48K |
| Operating profit | 14.13%72.22M | -65.82%1.19M | -27.15%97.09M | 173.49%84.12M | 204.13%63.28M | 333.30%3.48M | -38.69%133.27M | -73.46%30.76M | -188.69%-60.77M | -148.11%-1.49M |
| Add:Non operating Income | -30.19%296.17K | 42.52%293.22K | 51.69%1.3M | 3.68%626.5K | 6.15%424.26K | -5.60%205.74K | 1.01%854.05K | -5.01%604.25K | -4.57%399.69K | 9.35%217.93K |
| Less:Non operating expense | 21.62%333.04K | -89.83%153.99K | -53.21%857.08K | -40.10%833.69K | -66.50%273.83K | 96.29%1.51M | -20.43%1.83M | -35.81%1.39M | -61.99%817.4K | -37.98%771.47K |
| Total profit | 13.80%72.19M | -38.83%1.33M | -26.28%97.53M | 179.98%83.91M | 203.67%63.43M | 206.22%2.17M | -38.73%132.29M | -73.80%29.97M | -191.62%-61.19M | -199.46%-2.05M |
| Less:Income tax cost | 135.63%1.84M | 85.94%-930.61K | -119.37%-10.92M | 12.82%-5.9M | 79.45%-5.17M | 3.42%-6.62M | -240.63%-4.98M | -90.17%-6.77M | -1,565.52%-25.17M | -135.73%-6.86M |
| Net profit | 2.54%70.34M | -74.30%2.26M | -21.00%108.45M | 144.45%89.81M | FLtoP68.6M | 82.83%8.79M | -35.37%137.27M | -68.85%36.74M | SL-36.02M | -3.13%4.81M |
| Net profit from continuing operation | 2.54%70.34M | -74.30%2.26M | -21.00%108.45M | 144.45%89.81M | 290.46%68.6M | 82.83%8.79M | -35.37%137.27M | -68.85%36.74M | -155.36%-36.02M | -3.13%4.81M |
| Less:Minority Profit | -177.16%-129.05K | -1,356.54%-87.52K | 75.51%-177.51K | 4.23%-80.34K | 460.98%167.26K | 106.01%6.97K | 20.78%-724.9K | 87.80%-83.89K | 88.86%-46.34K | 23.68%-115.88K |
| Net profit of parent company owners | 2.97%70.47M | -73.29%2.35M | -21.28%108.63M | 144.11%89.89M | 290.24%68.44M | 78.39%8.79M | -35.30%138M | -68.95%36.82M | -154.94%-35.97M | -3.74%4.93M |
| Earning per share | ||||||||||
| Basic earning per share | 0.00%0.07 | --0 | -15.38%0.11 | 125.00%0.09 | 333.33%0.07 | --0.01 | -38.10%0.13 | -63.64%0.04 | -150.00%-0.03 | --0 |
| Diluted earning per share | 0.00%0.07 | --0 | -15.38%0.11 | 125.00%0.09 | 333.33%0.07 | --0.01 | -35.00%0.13 | -63.64%0.04 | -150.00%-0.03 | --0 |
| Other composite income | 230.81%140.74K | 108.95%30.88K | 42.85%-657.35K | 86.32%-164.8K | 84.75%-107.59K | 25.33%-345.11K | 64.93%-1.15M | 31.61%-1.2M | -117.88%-705.63K | -123.47%-462.15K |
| Other composite income of parent company owners | ---- | 108.95%30.88K | ---- | 86.32%-164.8K | ---- | 25.33%-345.11K | ---- | 31.61%-1.2M | ---- | -123.47%-462.15K |
| Total composite income | 2.90%70.48M | -72.89%2.29M | -20.81%107.79M | 152.27%89.65M | 286.51%68.5M | 94.33%8.45M | -34.90%136.12M | -69.41%35.54M | -153.21%-36.73M | -37.30%4.35M |
| Total composite income of parent company owners | 3.34%70.61M | -71.83%2.38M | -21.10%107.97M | 151.90%89.73M | 286.29%68.33M | 89.12%8.44M | -34.84%136.85M | -69.52%35.62M | -152.83%-36.68M | -37.01%4.46M |
| Total composite income of minority owners | -177.16%-129.05K | -1,356.54%-87.52K | 75.51%-177.51K | 4.23%-80.34K | 460.98%167.26K | 106.01%6.97K | 20.78%-724.9K | 87.80%-83.89K | 88.86%-46.34K | 23.68%-115.88K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg